MUNDELEIN, Ill., Aug. 19 /PRNewswire/ -- Bio-logic Systems Corp.
(Nasdaq: BLSC), a designer and marketer of computerized medical
electro-diagnostic equipment, today reported that its board of directors has
authorized the purchase of up to 100,000 shares of the company's outstanding
common stock.  The company had approximately 4.0 million shares of common
stock outstanding at June 30, 1998.  The company said the purchases will be
made from time to time at market price, through January 31, 1999, depending
upon prices and market conditions.
    "We continue to be confident in the long-term outlook for the company, and
as such, believe that our stock is a compelling value at today's market
price," said Bio-logic Systems Corp. President and Chief Executive Officer,
Dr. Gabriel Raviv.  "At its current level we believe the stock repurchase is a
prudent investment for our company."
    Bio-logic Systems Corp., headquartered in Mundelein, Ill., designs,
develops, assembles and markets computer-based electro-diagnostic systems for
use by hospitals, clinics, universities and physicians.  The systems conduct
tests that are typically used by medical practitioners to aid in the diagnosis
of certain neurological, psychiatric and sensory disorders, psychological
and learning disorders, brain disorders and tumors.
    Except for descriptions of historical facts, this release contains
forward-looking statements that involve known and unknown risks, which may
cause the company's actual results in the future to differ materially from
those currently anticipated.  These risks include, among others, fluctuations
in sales and operating results; risk associated with international operations
including monetary crisis; regulatory, competitive, and contractual risks; the
effects of economic conditions; any delays or additional costs associated with
the introduction of the AuDX product; and the availability of capital to
finance planned growth, as well as other risks detailed from time to time in
the company's filings with the Securities and Exchange Commission.

Link to this page: